1. Introduction {#sec1}
===============

Increasingly widespread availability of multi-omics datasets is a driving force in the study of diverse biological phenomena. The joint analysis of messenger RNA (mRNA), micro-RNA (miRNA), proteomics, and other kinds of omics data has become central to many areas in biomedical and biological research. However, it is increasingly recognised that working with multi-omics data poses various challenges, among which data hosting, reproducibility of analyses, and availability of resources for integrative data visualization and exploration are at the top of the list ([@bib5]; [@bib30]). There are various efforts being pushed in the development of storage, analysis and visualization capabilities that specifically target multi-omics data ([@bib30]).

Omics datasets are stored on both public and private repositories---often large, multi-database repositories such as the ones provided by the National Center for Biotechnological Information (NCBI) ([@bib24]), the European Bioinformatics Institute (EBI) ([@bib6]) or the National Genomics Data Center (NGDC) ([@bib32]). However, the majority of these repositories are limited to a single type of omics data.

As for analysis and visualization tools, a number of powerful tools exist, generally falling into one of two categories.

On the one hand, there are integrated databases and tools that focus on a specific task or biological theme: functional enrichment tools, such as ToppGene ([@bib3]), pathway databases, such as KEGG ([@bib13]) and Reactome ([@bib12]), and miRNA-mRNA interaction databases, such as miRTarBase ([@bib11]). Generally speaking, these are available on the web and serve a single specific purpose.

On the other hand, there are powerful general-purpose analysis tools, such as Cytoscape ([@bib27]), or R ([@bib23]) (with suitable third-party libraries) which allow for standalone analysis, including network construction and editing, once the software environment has been properly configured and auxiliary tools and databases have been connected. Such general purpose tools are powerful, but they generally are not pre-packaged with integrations with other tools and databases---users must build or at least configure these themselves---and they require users to learn a wide array of general-purpose functionality, determine which of those functions suit their needs, and use them to construct a suitable workflow. In the case of R, programming skills are also needed. Moreover, even these general purpose tools often do not provide the full set of functionality necessary to analyse multi-omics datasets, requiring users to work with multiple such tools to conduct these analyses.

Thus, despite the growing number of existing tools, and following the conclusions of ([@bib30]) there is a need for a single, integrated application in which a complete multi-omics analysis can be performed. To best support multi-omics research, such an application needs to facilitate the following: (1) storing and providing efficient access to heterogeneous data; (2) analysing data and identifying new features both within individual datasets and in the relationships between multiple datasets; and (3) reviewing the analysis results, all in order to facilitate knowledge discovery and dissemination.

Here, we introduce *Panomicon,* an actively developed application that aims to fulfill this need by integrating various data sources and analytics and combining these with visualizations and open/ended data import and export, all in the web browser. We believe that this is the best way to leverage existing resources to enable powerful collaborative data analysis.

Panomicon implements the following functionality:1.In order to support storage and efficient data access, it implements a data model that supports the integration of multiple data types (demonstrated here through the simultaneous storage of mRNA and microRNA, although the concepts generalize to other types as well);2.For the analysis and identification of new features in data, it provides fast, interactive, dynamic generation and regeneration of networks, based on mRNA-miRNA interaction databases that have been preloaded into the application; and3.Finally, to facilitate the review of the analysis results, it allows the presentation and visualization, both in dual tables and through conventional 2-dimensional display of nodes and edges graphs, of the generated networks.

Panomicon positions itself as a whole workflow support platform that allows end-to-end integration and analysis of multi-omics data.

Panomicon provides a rich, web-based integrated environment for multi-omics data analysis with data upload and management capabilities. We think that this would be especially helpful for groups of people wishing to analyse the same data, whether in a single laboratory or across multiple institutions. In such a setting, one person could act as the data uploader and manager, while others could explore and analyse the data that has been uploaded. Administrators can also create their own managed versions of Panomicon, given that it is open source, rather than use the server that we provide. In this way, Panomicon offers a solution to collaborative data analysis and management needs, while at the same time providing everything needed for individuals to establish their own multi-omics databases, even at large scale. All tools in Panomicon can handle large datasets and have been tested on more than 20,000 samples and 800 million data points in a single database.

We emphasise particularly the efficiency of Panomicon\'s network manipulation engine. A network consisting of all mRNA and miRNA probes, as well as interactions between them, can be manipulated in-memory on the server, while users can inspect and visualise a partial view of this network. Because only a small amount of data needs to be sent to the user, even for large networks consisting of over 100,000 nodes, updating, sorting, and filtering takes 1--2 s. To the best of our knowledge, this is unique among web-based multi-omics analysis tools.

Furthermore, the tools in Panomicon are specifically designed for omics analysis, particularly mRNA and miRNA data, and comparative analysis of different sample conditions, such as treated and control groups. It contains a pre-designed data environment where many widely used databases and third party data sources, such as mRNA-miRNA interaction databases, pathways, and gene ontology (GO) terms, are already available. Since tools and data access in Panomicon have all been developed together with this domain in mind, many valuable studies can be performed with very little configuration and without external software, which would be required when conducting similar analyses with more general purpose tools. Further details can be found in the Panomicon user guide (available at <https://toxygates.nibiohn.go.jp/panomicon/toxygatesManual.pdf>) and in our paper about Panomicon\'s precursor ([@bib34]).

Panomicon is freely available to the public at <https://toxygates.nibiohn.go.jp/panomicon>. The source code of the web application is also available, under a GNU General Public License v2.0, at <https://github.com/Toxygates/Panomicon>.

2. Results {#sec2}
==========

Three kinds of functionality make up the core of *Panomicon*: (1) handling of multi-omics data; (2) dynamic generation of networks; and (3) interactive visualization of networks. In this section, we discuss each of them in detail.

2.1. Multi-omics data handling {#sec2.1}
------------------------------

To provide fundamental support for this kind of data analysis, Panomicon accommodates multiple types of omics data. The system is divided into multiple screens that support various workflows. On the sample group definition screen, where an analysis can be started by selecting experimental samples to include in a sample group to be analysed, users can select an omics data type such as mRNA or miRNA in addition to sample conditions. Sample groups allow expression values for an omics type to be averaged across the samples contained in the group. To perform analyses involving multiple data types, users can create one or more groups of each type. Whenever multiple groups with different data types are activated simultaneously in this way, the "dual table" mode, described below, will be activated.

2.2. Linked expression data tables {#sec2.2}
----------------------------------

On the data screen, where users can view expression values and other data for their selected sample groups, we have introduced a split table (\"dual table\") view that simultaneously displays data from two different omics types (If only a single type of sample has been chosen, then a simpler single table view is displayed instead). In this view, two tables are active simultaneously, each corresponding to one data type. For example, the left (primary) table might display mRNA data, in which case the right (secondary) table would display miRNA data. Users can switch the positions of the two tables by clicking a button that \"flips\" the tables.

In the dual table view, the left-hand table is always considered to be the main table. It drives the display of the right-hand table, which is considered to be secondary. The main table can be controlled through paging, sorting, filtering, and choosing particular gene sets of interest, which indirectly also controls the right table. For example, if the main table, after user operations such as filtering and sorting, displays a set of 50 mRNAs, then the right table will immediately display those miRNAs that are associated with these 50 mRNAs. mRNA-miRNA association sources are configured by the user to construct the dual table view. Currently we include, for human, rat and mouse data, miRTarBase ([@bib11]) and miRDB ([@bib2]); and for human data, prediction results from miRAW ([@bib22]). These can be filtered by score and support type cutoffs.

2.3. Visual network analysis {#sec2.3}
----------------------------

By using the cytoscape. js library ([@bib8]), we have added interactive network visualization capabilities to Panomicon. These capabilities have been deeply integrated with previously existing functions for gene set management as far as possible, as we will show below.

To construct a network, it is first necessary to load a dual table display of two omics types, as described above. When the user activates network visualization, the application will construct a network by taking probes from the main table (for example, mRNA probes), based on the currently active sort order and expression value filters (for example, with respect to *p*-values and log-2 fold values), then adding probes from the right table, together with their interactions (regulatory relationships, in the case of mRNAs being regulated by miRNAs). The interaction network will represent probes from the main and secondary tables as nodes, and interactions between probes as edges.

Such a network is fully defined by the following parameters:•The mRNA and miRNA sample groups for which expression values are being displayed in the two tables•The chosen miRNA-mRNA association sources and any cutoff limits applied to them•The probes visible in the main table (for example, those associated with a chosen gene set)•Any filtering that the user may have applied to the primary and secondary tables.

In the network visualization, a size limit cutoff may apply, with probes being selected according to the sort order of mRNAs or miRNAs applied by the user. The main reason for limiting the size of networks (currently networks are limited to a maximum of 100 nodes of the primary type, with no limit for the secondary type) is to speed up the network layout process and user interactions, since many network layout algorithms become slow when the network is large.

In designing the network analysis functions our principle is to allow multiple analysis functions to work together in an open-ended, interactive environment supporting many use cases. Networks can be constructed from gene sets, and conversely the nodes in networks can be saved as gene sets. As described above, filtering and sorting of gene sets is reflected in network display. It is also possible to interactively tune network parameters and inspect the results visually, until one is satisfied with the overall outcome. For example, filters on expression values in data columns as well as the choice of miRNA-mRNA associations may be edited directly from the network display, without closing the network view. Such changes are immediately reflected in a new, updated network. This allows users to gradually adjust filters until the desired outcome is obtained.

It is also possible to comparatively analyse two networks side by side and highlight common nodes. For example, networks based on two different experimental conditions or on two different filtering conditions can easily be compared. In such an analysis it is easy to find the location of common nodes in the networks, as selecting a node in one of them---either in the left or in the right network---will highlight the node corresponding to the same probe in the other network, if one exists. Such side-by-side networks can at any time be merged together and automatically laid out again in a way that intuitively highlights features shared by the two networks. Merging two networks in this way places common nodes in a visually separate area for easy identification.

In summary, Panomicon supports simultaneous analysis of mRNA and miRNA so that networks can be constructed by choosing a gene set of either of the two types as a starting point. While inspecting and manipulating such networks, whether in dual table mode or in network visualization mode, the user can construct new gene sets of either type. Thus, it is possible to draw immediate conclusions from networks as well as downstream conclusions from further analysing derived gene sets. All of these operations are sufficiently general to apply to any pair of omics types, as long as quantitative probe data and interaction pair data is available. For example, as a next step in Panomicon development, we are considering co-analysis of proteomics and mRNA data. In such a case, by designating mRNA data as a common denominator it is theoretically possible to compare mRNA, miRNA, and proteomics data simultaneously by inspecting mRNA-protein and mRNA-miRNA networks.

2.4. Case study {#sec2.4}
---------------

In an effort to identify biomarkers for Non-Small Cell Lung Cancer (NSCLC), Ma and colleagues ([@bib16]) used microarrays to measure the expression levels of miRNA and mRNA simultaneously in paired NSCLC and adjacent normal tissues for 6 patients. Using TargetScan ([@bib1]) they identified the down-regulated mRNA targets for hsa-miR-96 and then performed Gene Ontology enrichment for Biological Process using WebGestalt ([@bib15]). Their conclusion was that hsa-miR-96 has potential as a biomarker for NSCLC.

To demonstrate the capabilities of Panomicon, we will replicate the whole of the analysis undertaken by [@bib16]. We will show that it is possible to store multi-omics datasets on Panomicon and use the integrated functionalities available to find relationships between different data types, analyse them, and review the biology behind the generated results. All these operations require little to no interaction with other repositories or tools.

[Figure 1](#fig1){ref-type="fig"} summarizes the flow of activities that can be performed using Panomicon. In the following, we give details on how these can be used to replicate the study of NSCLC data.Figure 1**Sample analysis workflow for Panomicon.** Panomicon\'s flexible implementation gives users a large degree of freedom in analysing data, starting from the optional Data Upload stage.Figure 1

The original data used by Ma and colleagues is publicly available on the Gene Expression Omnibus. In addition, for the purpose of this exercise, this data has been uploaded and made publicly available as part of the *GEO* dataset on Panomicon. A detailed description of the upload process can be found in the supplementary file "Panomicon - a case study" provided together with this manuscript.

Although the example studied here is relatively small for the sake of simplicity, Panomicon has been tested with large databases of over 20,000 samples. Panomicon contains separate tools for the efficient management of such large datasets. Thus, the methods we demonstrate below can also be used in the same fashion to analyse large scale data, which makes Panomicon a suitable technology choice for groups that want to create their own large multi-omics databases.

Data selection in Panomicon is achieved through the definition of *Sample Groups*, i.e., lists of experimental samples to be analyzed. Our study deals with the relationship between mRNA and miRNA expression values, so two sample groups need to be defined: one for mRNA and one for miRNA. The *NSCLC mRNA* sample group is defined using all Adenocarcinoma and Squamous samples available for the *mRNA/human/in vivo/lung/simple* combination. Similarly, the *NSCLC miRNA* sample group is defined using all samples available when selecting the *miRNA* option in the first drop-down box of the data source selection controls.

Once two sample groups have been defined, it is possible to generate a network. For the generation of mRNA-miRNA networks, a number of sources for mRNA-miRNA interactions are available for use on Panomicon. Here we choose *miRTarBase* ([@bib11])*,* with a "Functional MTI" support type as cutoff, so as to include only experimentally verified relations.

Next, the network must be pruned, in order to focus on the subgraph consisting only of miRNA hsa-miR-96-5p and its target genes. To do so, the network construction must be driven through a selection of miRNA probes, and a *gene set* consisting only of hsa-miR-96-5p must be enabled.

By convention, the probes in the left table (in the *View Data* tab) drive the search for targets, which are displayed in the right table. Thus, to analyze a network driven by the specification of miRNA elements, we first need to exchange the position of the two omics data types. This can be done by clicking on the *Flip mRNA-miRNA* button.

Once miRNA expression values are displayed on the left table we use the *Gene Sets* menu to search for hsa-miR-96-5p. Applying a *gene set* restricts a table view to only the probes or genes contained in the set. In our case, once the *gene set* is saved (and thus automatically applied), hsa-miR-96-5p is shown in the miRNA table on the left, and only mRNA targeted by hsa-miR-96-5p are shown in the right table. This list consists of 26 target genes (in 114 individual probes).

To visualize this network using a traditional node and edge representation, the user simply needs to select the corresponding option from the *Network* menu of the *View Data* tab.

Since the original authors' interest lies in the identification of targets for the treatment of NSCLC, we focus on the genes that depict an up-down regulation relationship to miR-96, i.e., those that are down-regulated due to upregulation of miR-96. This highlighting of the network can be achieved via the application of a color scale.

Furthermore, filters can also be used to prune elements from the visualization. In the visualization screen, we define a filter to be applied to mRNA elements whose log2 fold change is less than or equal to 0. The displayed network reduces to only 10 genes, in 11 individual probes.

[Figure 2](#fig2){ref-type="fig"} shows the pruned network, that includes only hsa-miR-96-5p and its down-regulated targets. Notice that, in accordance with the applied color scale, all mRNA are displayed using different shades of red, indicating down-regulation, whilst miR-96 is shown in blue due to its up-regulation.Figure 2**Network of Down-regulated targets for hsa-miR-96-5p.** Notice that although only 10 individual target genes are found, two probes associated with BDNF are shown separately.Figure 2

In the final step in demonstrating Panomicon\'s capacity to handle a complete analysis pipeline, we perform functional enrichment analysis in order to investigate the biological context behind the generated network and explore its relation to biological processes.

Functional enrichment analysis in Panomicon can be performed thanks to its integration with TargetMine ([@bib4]), a data warehouse for drug discovery. The functional enrichment analysis is performed using the list of genes currently driving the network generation (left-hand side of the table view), so in order to perform it, we must select the targets from the network.

From the network visualization, we first save the network, then select the *Save probes as gene set* option of the *Network* menu to extract a Gene set that includes only mRNA probes. Finally, we apply the gene set, making sure that mRNA samples are currently being displayed on the left-side table. The functional enrichment analysis is then performed from the *Tools* menu.

We perform two different types of functional enrichment analysis. First, we perform GO Term enrichment analysis using the following configuration: Biological-process filtering, 0.1 *p*-value cutoff (no results were found under a 0.05 threshold value), and Benjamini-Hochberg correction. The complete list of enriched terms is shown in [Table 1](#tbl1){ref-type="table"}. Second, we perform functional enrichment analysis against the KEGG database, using a *p*-value cutoff of 0.05 and a Benjamini-Hochberg correction. The complete list of enriched pathways is shown in [Table 2](#tbl2){ref-type="table"}. In the following, we provide some biological interpretations of these results.Table 1**Gene Ontology enrichment.** List of all GO terms enriched (biological process) for the set of down-regulated genes found using Panomicon\'s integration to TargetMine. Holm-Bonferroni correction, p-value \< 0.1.Table 1IDDescriptionp-valueMatchesGO:0051402Neuron apoptotic process0.06003GO:0010604Positive regulation of macromolecule metabolic process0.06198GO:0012501Programmed cell death0.06647GO:0009267Cellular response to starvation0.06733GO:0006915Apoptotic process0.06767GO:0043523Regulation of neuron apoptotic process0.07053GO:0031325Positive regulation of cellular metabolic process0.07148GO:0008219Cell death0.07307GO:0010508Positive regulation of autophagy0.07393GO:0042594Response to starvation0.07803GO:0010941Regulation of cell death0.07876GO:0051173Positive regulation of nitrogen compound metabolic process0.08378GO:0043067Regulation of programmed cell death0.08706GO:0009893Positive regulation of metabolic process0.09518GO:0042981Regulation of apoptotic process0.09926Table 2**KEGG Pathway Enrichment results.** List of KEGG enriched pathways found for the set of down-regulated genes using Panomicon\'s integration with TargetMine. Benjamini Hochberg correction, p-value \< 0.05.Table 2IDDescriptionp-valueMatcheshsa05223Non-small cell lung cancer0.00614ALK\
CDKN1A\
FOXO3hsa04068FoxO signaling pathway0.0240CDKN1A\
FOXO1\
FOXO3hsa04218Cellular senescence0.0289CDKN1A\
FOXO1\
FOXO3hsa05202Transcriptional misregulation in cancer0.0338CDKN1A\
FOXO1\
MITFhsa05200Pathways in cancer0.0382ALK\
CDKN1A\
FOXO1\
MITF

Among the GO Term results, we highlight the enrichment of "Apoptotic process". It is widely known that apoptosis is suppressed in cancer cells due to the mutation of p53. Wild-type p53 is a potent inducer of apoptosis, but the expression of p53 is down-regulated in lung cancer tumor tissue compared with non-tumor tissue ([@bib19]; [@bib29]). Accordingly, Panomicon shows that gene expression of Tumor Protein P53 Inducible Nuclear Protein 1 (TP53INP1) is down-regulated by miR-96-5p (see [Figure 2](#fig2){ref-type="fig"}), which phosphorylates p53 and is involved in inducing apoptosis ([@bib21]; [@bib26]).

As for the enriched pathways, worth noticing are pathways entitled "Non-small cell lung cancer" and "FoxO signaling pathway", where the matched genes for the first pathway are ALK, CDKN1A, (also called p21) and FOXO3 whilst those for the second pathway are p21, FOXO1, and FOXO3 (see [Table 2](#tbl2){ref-type="table"}).

It has been shown that p21, together with p53, is involved in cell cycle arrest when down-regulated in tumor tissue ([@bib20]; [@bib33]). FOXO1 and FOXO3 are involved in inducing apoptosis and both have been found to be related to Non-small cell lung cancer progression when down-regulated ([@bib10]; [@bib17]; [@bib18]; [@bib28]). Thus, the results found with Panomicon are consistent with what one would expect biologically.

There is one aspect of our results which are contrary to previous findings: ALK has been found to be up-regulated in lung cancer tumor tissue ([@bib31]). However, ALK is widely known as a fusion gene: the C-terminus of ALK protein fuse with several proteins and the expression of ALK gene in lung cancer cells is different in each exon ([@bib9]; [@bib25]), which in turn could explain the difference between our results and previous reports.

3. Discussion {#sec3}
=============

The growing availability of multi-omics datasets has become a driving force in the study of diverse biological phenomena. However, together with the opportunities these new datasets provide, a series of new challenges, including data hosting, reproducibility of analyses, and facilitation of integrative data exploration are also introduced ([@bib5]).

We address all of these issues by introducing Panomicon, a web-based integrated environment suitable for the storage, analysis, and visualization of multi-omics datasets, with a focus on the analysis of biological networks.

To achieve this goal, Panomicon introduces the following core functionalities:1.Data handling. Extension of the underlying data structure model to accommodate the storage and handling of multiple types of omics datasets.2.Network generation. Built-in interaction databases that allow elements from different omics types to be linked together, allowing the generation of biological networks3.Network visualization and analysis. Integration of the Cytoscape. js library to allow the visual display of the generated networks and provision of functionality for the analysis, persistence and sharing of networks.

Panomicon adheres to open source development methods, and provides integrated access to other biological resources, such as TargetMine.

The design philosophy of Panomicon emphasizes an interactive environment with multiple interacting tools that can be combined freely, as well as a hybrid data model, to support these tools. The hybrid data model also allows for two kinds of scalability: quantitative scaling of the data (where large volumes of data are supported) and increasing complexity of data (where unforeseen or unexpected data structures are supported). Panomicon has built on these concepts. Different tools in Panomicon communicate by passing gene sets and networks to each other as well as by generating gene sets from networks and vice versa, as we have shown in the case study above. Dual table networks can scale to tens of thousands of probes (genes) on either side of the table and respond instantly to sorting and filtering.

The major strength of Panomicon is its suitability for supporting entire biological workflows, from data storage to analysis, visualization, and biological interpretation. This is demonstrated by our case study, where the need for multiple software tools is obviated by the different functionalities integrated into Panomicon. A step-by-step guide for the replication of our case study is provided as supplementary information. Moreover, with the improvements described above, Panomicon now fundamentally supports a wide range of multi-omics datasets.

The use of Panomicon is not limited by the data and functionality currently implemented in the publicly available version. Thanks to its efficient data model and open source philosophy, Panomicon can be deployed by institutions to create new large scale multi-omics databases with integrated capabilities for collaborative data analysis.

3.1. Future directions {#sec3.1}
----------------------

We see the potential for Panomicon to be used even more widely by researchers as well as application developers working with multi-omics data. To that end, in the future we plan to pursue the following improvements:1.Further generalizing the user interface and data model, as well as importing more data sets of general interest;2.Developing system-wide support for more omics types and platforms, to facilitate import and work with different kinds of data, and3.Providing well-defined and documented configurability and extensibility which, together with the open-source spirit that informs the development of Panomicon, would allow users to develop their own derived applications to meet the needs of their own research.

4. Experimental procedures {#sec4}
==========================

4.1. Resource availability {#sec4.1}
--------------------------

### 4.1.1. Lead Contact {#sec4.1.1}

Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Rodolfo S. Allendes Osorio (<rallendes@nibiohn.go.jp>).

### 4.1.2. Materials availability {#sec4.1.2}

This study did not generate new unique reagents. There are no restrictions for use of the software presented.

### 4.1.3. Data and code availability {#sec4.1.3}

The dataset analyzed in this article, GSE29250 ([@bib16]), is publicly available from the Gene Expression Omnibus (GEO) at <https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29250>.

Panomicon is an open source project, released under a GNU General Public License v2.0. The main application URL is <https://toxygates.nibiohn.go.jp/panomicon/>. The source code for Panomicon can be found at: <https://github.com/toxygates/panomicon>. Documentation can be found at <https://toxygates.nibiohn.go.jp/panomicon/toxygatesManual.pdf>.

4.2. Method details {#sec4.2}
-------------------

To help construct miRNA-mRNA networks in Panomicon, we have added the miRBase v. 21 miRNA set ([@bib14]) and several miRNA-mRNA association sources. MiRDB v5.0 contains predicted targets for human, mouse and rat ([@bib2]). miRTarBase contains experimentally verified targets for human, mouse and rat ([@bib11]). Finally, the MiRAW algorithm was used to generate human predicted targets, using a novel method that applies deep learning to the entire transcript, and not only the predicted binding sites ([@bib22]). The parameters used to generate the data in Panomicon were 6_1\_10_AE10 NLL (candidate binding site contains at least 6 base pairs between nucleotides 1 and 10, accessible energy filter -10 kcal/mol, negative log-likelihood).

The dataset GSE29250 was imported from the Gene Expression Omnibus (GEO) and preloaded to Panomicon. MicroRNA data, measured using the platform GPL8179 (Illumina Human v2 MicroRNA expression beadchip) was converted into mirBase identifiers using an approximate method. Messenger RNA data, originally measured using GPL10558 (Illumina HumanHT-V2 4.0 expression beadchip) was converted into RefSeq transcript identifiers using official annotations from Illumina. Ensembl release 99 [@bib7] was used to obtain further RefSeq annotations. The imported data can be found under the label 'GEO' in the list of Data Sources available to use in Panomicon. Detailed instructions for the uploading of this dataset are included in the Case Study supplementary guide, provided together with this manuscript.

The case study was performed on the publicly hosted version of Panomicon, available at <https://toxygates.nibiohn.go.jp/panomicon/>. This public version is maintained at the AI Center for Health and Biomedical Research, part of the National Institutes of Biomedical Innovation, Health and Nutrition, in Osaka, Japan.
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